Next, to compare the sensitivity and specificity for various tau seeds, brain lysates from AD, progressive supranuclear palsy (PSP), cortico basal degeneration (CBD), Pick’s disease (PiD), and control cases were tested in the original and novel biosensor cells (Fig. 4D). This evidence concerns the gene MAPT and progressive supranuclear palsy.